Variables | Frequency | Percent (%) |
---|---|---|
Sex | ||
Male | 139 | 38.1 |
Female | 226 | 61.9 |
Age | ||
18–30 | 80 | 21.9 |
31–45 | 198 | 54.2 |
46–60 | 77 | 21.1 |
> 60 | 10 | 2.7 |
Marital status | ||
Single | 54 | 14.8 |
Married | 162 | 44.4 |
Divorced | 109 | 29.9 |
Widowed | 40 | 11.0 |
Residence | ||
Urban | 325 | 89.0 |
Rural | 40 | 11.0 |
Educational status | ||
Unable to read and write | 121 | 33.2 |
Able to read and write | 45 | 14.8 |
Primary school | 91 | 24.9 |
Secondary school | 54 | 12.3 |
Diploma and above | 54 | 33.2 |
Occupations | ||
Governmental | 55 | 15.2 |
Privet | 13 | 3.6 |
Unemployed | 37 | 10.1 |
Agriculture | 37 | 10.1 |
Merchants | 72 | 19.7 |
House wife | 78 | 21.4 |
Daily labor | 73 | 20 |
WHO clinical stage | ||
Stage I | 211 | 57.8 |
Stage II | 70 | 19.2 |
Stage III | 51 | 14.0 |
Stage IV | 33 | 9.0 |
CD4-T cell count (cells/mm3) | ||
< 200 | 54 | 14.8 |
200–350 | 59 | 16.2 |
351–500 | 61 | 16.7 |
≥ 500 | 191 | 52.3 |
ART regimens | ||
AZT based regimen | 177 | 48.5 |
TDF based regimen | 173 | 47.4 |
Second line regimen | 15 | 4.1 |
Duration of HAART Intake (months) | ||
3–30 | 65 | 17.8 |
31–60 | 88 | 24.1 |
61–90 | 102 | 27.9 |
91–120 | 87 | 23.8 |
> 120 | 23 | 6.3 |
Body mass index (kg/m2) | ||
< 18.5 | 83 | 22.7 |
18.5–24.9 | 255 | 69.9 |
≥ 25 | 27 | 7.4 |
Dietary diversity score | ||
Adequate dietary diversity | 124 | 34.0 |
Inadequate dietary diversity | 241 | 66.0 |
Other drugs intake | ||
Yes | 112 | 30.7 |
No | 253 | 69.3 |
Alcohol intake | ||
Yes | 83 | 22.7 |
No | 282 | 77.3 |